EANS-Adhoc: - Dr. Dr. h.c. Thomas Middelhoff new chairman of the supervisory
board of Marseille-Kliniken AG
- Previous chairman Uwe Bergheim stays on as member of the supervisory board,
Hans-Hermann Tiedje remains deputy chairman
--------------------------------------------------------------------------------
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
adhoc with the aim of a Europe-wide distribution. The issuer is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------
28.09.2011
Hamburg, 28 September 2011. Uwe Bergheim has resigned as chairman of the
supervisory board of Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003,
MKA) on 27 09 2011 due to personal reasons. He stays on as member of the board,
likewise as member of the finance and audit committee. The supervisory board of
Marseille-Kliniken AG elected from among its members Dr. Dr. h.c. Thomas
Middelhoff as new chairman of the supervisory board at yesterday´s meeting.
Hans-Hermann Tiedje remains unchanged as deputy chairman of the supervisory
board.
End of ad hoc release
Further inquiry note:
Hillermann Consulting
Christian Hillermann
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 320 279-10
Fax: +49-(0)40 / 320 279-114
www.hillermann-consulting.de
end of announcement euro adhoc
--------------------------------------------------------------------------------
issuer: Marseille-Kliniken AG
Alte Jakobstraße 79/80
D-10179 Berlin
phone: +49 (0)30 246 32-400
FAX: +49 (0)30 246 32-401
mail: info@marseille-kliniken.de
WWW: http://www.marseille-kliniken.de
sector: Pharmaceuticals
ISIN: DE0007783003
indexes: CDAX, Classic All Share, Prime All Share
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
Stuttgart, Düsseldorf, regulated dealing: Hamburg
language: English
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 11.06.2010 Berlin, 11 June 2010. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) has appointed Dr. Thomas Klaue (52) to the Management Board ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. quarterly report 10.05.2010 Berlin, 10 May 2010. The Marseille-Kliniken Group (Prime Standard, ISIN DE ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Disposing of rehabilitation division completed 30.04.2010 Berlin, 30 April 2010. Marseille-Kliniken Group (Prime Standard, ISIN DE 0007783003, MKA) has completed the ...